Randomized Clinical Trial of Aspirin and Simvastatin for Pulmonary Arterial Hypertension - ASA-STAT


By targeting platelet activation and endothelial dysfunction, aspirin and statins have the potential to improve outcomes in patients with pulmonary arterial hypertension (PAH). The current trial was a phase II trial designed to study the feasibility of the use of aspirin and simvastatin in patients with PAH.